advertisement
11.13.2 Betablocker and carbon anhydrase inhibitor (11)
Showing records 1 to 11
Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor
Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Kumbar SK
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8
61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Inoue K
Clinical Ophthalmology 2015; 9: 619-623
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Kim YI; Kim JH
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Mirje M
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8
61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Shiokawa M
Clinical Ophthalmology 2015; 9: 619-623
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Lee TY
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Ishida K
Clinical Ophthalmology 2015; 9: 619-623
61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Moharir G
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Lee KW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Bharatha A
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8
61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Tomita G
Clinical Ophthalmology 2015; 9: 619-623